DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Referenz

Ekert H, Brizard C, Eyers R, Cochrane A, Henning R.
Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy.

Blood Coagul Fibrinolysis 2006;
17 (05) 389-395

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in:
Aufrufen in: